Meituan

Meituan operates China’s largest on-demand services and local commerce platform. It leads the market in food delivery and has diversified into hotel booking, travel, ride-hailing, grocery e-commerce, and more. The company leverages AI and logistics technology to optimize operations and user experience. It reported robust revenue growth in 2025 but faces margin pressure due to heavy investment in subsidies and international expansion. In healthcare specifically: Meituan has partnered with GSK China to build an online-to-offline pharmacy model for OTC drugs but does not develop therapeutics or diagnostics itself. As an investor: Meituan invests in biotech/life science companies such as Qitan Technology but does not operate these businesses directly. No clinical results or drug pipeline exist for this entity.